focus -WSS

focus

author：knowledge 2025-09-28 21:06:40 - browse：66

New Sanofi Genzyme president Bill Sibold is the first person without any ties to Henri Termeer (inset) to lead the company. Jonathan Wiggs/Globe staff

CAMBRIDGE, Mass. — When drug giant Sanofi restructured its global business two years ago, its Genzyme division got a new name, Sanofi Genzyme, explicitly tying it to the French parent company. It also got new responsibilities and a larger “specialty care” portfolio covering everything from enzyme replacement to cancer and multiple sclerosis drugs.

Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold. He’s the first one without any ties to the old Genzyme, an independent company that pioneered the rare-disease business model and catalyzed the local life sciences boom before accepting Sanofi’s $20.1 billion takeover offer in 2011.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： H.R. 3 is the wrong path to lower drug costs

focus

leisure time

WSS

Group behind ProMed defends move to subscription

Readers respond to H5N1 and livestock movements, and more

It's time to retire 'poor historian' from clinicians' vocabularies

It costs an awful lot of money to give away a kidney

Alnylam reports growth in sales of rare disease treatments

Readers respond to H5N1 and livestock movements, and more

hotspot

focus

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Alnylam reports growth in sales of rare disease treatments

United colonoscopy coverage change 'may cost lives,' doctors say

Solving academic medical centers' existential crisis

Anesthesiologist group: stop taking Ozempic before surgery

Heart disease in astronauts blamed on cosmic radiation

As demand for Covid shots wanes, Moderna seeks its next success

Physicians aren't 'burning out.' They're suffering from moral injury

Medical leaders decry Supreme Court decision on affirmative action

Chris Christie meets with Zelenskyy during Ukraine trip

leisure time

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Heart disease in astronauts blamed on cosmic radiation

Cytokinetics CEO stresses company can launch heart drug on its own

focus

leisure time

hotspot

leisure time